Pasurta

Pasurta

erenumab

Manufacturer:

Novartis

Distributor:

DKSH
Concise Prescribing Info
Contents
Erenumab
Indications/Uses
Migraine prophylaxis in adults w/ at least 4 migraine/mth.
Dosage/Direction for Use
Contraindications
Special Precautions
Discontinue use if severe hypersensitivity reactions occur. Not to be inj in tender, bruised, red or hardened skin. Latex-sensitive individuals. Severe renal impairment (eGFR <30 mL/min/1.73 m2). Pregnancy & lactation. Ped.
Adverse Reactions
Inj site reactions; constipation; muscle spasm; pruritus.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD01 - erenumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Pasurta soln for inj 70 mg/mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in